Related references
Note: Only part of the references are listed.Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
Chang Gon Kim et al.
JOURNAL OF HEPATOLOGY (2021)
HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α
Nanmu Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
The role of N6-methyladenosine mRNA in the tumor microenvironment
Min Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer
Wei Chong et al.
THERANOSTICS (2021)
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB
Sasithorn Wanna-udom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells
Jiexin Li et al.
CELLS (2020)
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
Bo Zhang et al.
MOLECULAR CANCER (2020)
The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang et al.
MOLECULAR CANCER (2020)
The RNA modification N6-methyladenosine as a novel regulator of the immune system
Ziv Shulman et al.
NATURE IMMUNOLOGY (2020)
Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
Jianhao Li et al.
FRONTIERS IN ONCOLOGY (2020)
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation
Chuanzhao Zhang et al.
ONCOGENE (2020)
m6A Reader: Epitranscriptome Target Prediction and Functional Characterization of N6-Methyladenosine (m6A) Readers
Di Zhen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy
Lingling Wang et al.
EMBO JOURNAL (2020)
New advances in the diagnosis and management of hepatocellular carcinoma
Ju Dong Yang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
Thomas Yau et al.
JAMA ONCOLOGY (2020)
Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma
Yoon Ah Cho et al.
CANCER GENOMICS & PROTEOMICS (2020)
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Dali Han et al.
NATURE (2019)
The role of m6A RNA methylation in human cancer
Xiao-Yu Chen et al.
MOLECULAR CANCER (2019)
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
Huamin Wang et al.
NATURE COMMUNICATIONS (2019)
The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA
Yihan Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
Jiajie Hou et al.
MOLECULAR CANCER (2019)
m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
Li Liu et al.
MOLECULAR CANCER (2019)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
The Role of Upregulated DDX11 as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma
Jianhao Li et al.
JOURNAL OF CANCER (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
METTL14 Suppresses the Metastatic Potential of Hepatocellular Carcinoma by Modulating N6-Methyladenosine- Dependent Primary MicroRNA Processing
Jin-Zhao Ma et al.
HEPATOLOGY (2017)
Post-transcriptional gene regulation by mRNA modifications
Boxuan Simen Zhao et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein
Zhe Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Recent advances in hepatocellular carcinoma therapy
Rinku Dutta et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Jittiporn Chaisaingmongkol et al.
CANCER CELL (2017)
Messenger RNA modifications: Form, distribution, and function
Wendy V. Gilbert et al.
SCIENCE (2016)
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Senbabaoglu et al.
GENOME BIOLOGY (2016)
The yin and yang of evasion and immune activation in HCC
Oxana V. Makarova-Rusher et al.
JOURNAL OF HEPATOLOGY (2015)
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Kate D. Meyer et al.
CELL (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Share Paper
